News

Make a difference in your community. Grow with a team that values you. Are you a passionate and experienced Registered Nurse who loves providing quality primary healthcare and making a meaningful difference in people’s lives? We are looking for a warm, motivated and patient-focused Registered Nurse to join our friendly GP clinic in South Auckland. As a teaching practice, we value learning, collaboration and the sharing of knowledge. We’re looking for someone who not only brings strong...

Permanent, full-time clinical role + based in Hamilton 2 Paid Wellbeing Days, Extra Annual Leave & more! Join a supportive work environment where work life balance is encouraged Utilise your clinical skills to develop and manage housing solutions, providing support to tāngata whaiora and whānau experiencing homelessness. LinkPeople | Mō mātou E whakapono ana mātou ko ngā tāngata te mea nui o te ao. At LinkPeople we believe that people are the most important thing in the world. This guides...

Below is the latest information on Pharmac consultations, notifications, and supply issues for Primary Care Prescribers for week 9 October 2026. It includes information on: New updates Discontinuations Reminders New updates Supply issue: Sildenafil (Vedafil) 50mg tablets There is a supply issue affecting sildenafil (Vedafil) 50mg tablets. Pharmac previously funded a Section 29 alternate brand, Sildenafil (Amarox), in August this year. Stock of this brand is now very low and is expected to be...

Pharmac has decided to fund a new medicine for people in hospital with serious infections and to improve access to medicines for difficult-to-treat bacterial infections and high blood pressure.From 1 November 2026, Pharmac will: Fund ceftolozane with tazobactam for people with serious multidrug-resistant bacterial infections. Widen access to bedaquiline and linezolid for people with non-tuberculous mycobacterial infections. Widen access to captopril oral liquid for people with spinal cord...

This systematic review and network meta-analysis evaluated the benefits and harms of add‑on oral antihistamines for atopic dermatitis (eczema).1 Forty‑seven randomised trials (6230 participants) assessed H1 antihistamines, H2 blockers, mast cell stabilisers, or combinations. With moderate certainty, first‑ and second‑generation H1 antihistamines produced small reductions in eczema severity (mean difference −1.87) and itch (mean difference−0.89), far below the minimal important differences....

Flamazine cream discontinuation The supplier, Smith & Nephew, will stop supplying Flamazine cream (Pharmacode: 2343851) sulfadiazine silver 1% to the New Zealand market. Stock is expected to run out in December 2026/January 2027. Flamazine cream discontinuation Glibenclamide (Daonil) tab 5 mg discontinuation The supplier, Sanofi, is discontinuing Daonil (glibenclamide) tab 5 mg globally. Stock is expected to run out in February 2027. Glibenclamide (Daonil) tab 5 mg discontinuation Updated...